| 1 | between | 184,635 |
| 2 | vc-da | 4 |
| 3 | 2-containing | 3 |
| 4 | be-tween | 2 |
| 5 | betweem | 2 |
| 6 | bewteen | 2 |
| 7 | ofboth | 2 |
| 8 | uring | 2 |
| 9 | of | 2 |
| 10 | -138.31 | 1 |
| 11 | -33.39 | 1 |
| 12 | 0·138 | 1 |
| 13 | 11/0402 | 1 |
| 14 | 13.9±25.6 | 1 |
| 15 | 13/0503 | 1 |
| 16 | 1403.3 | 1 |
| 17 | 16.3-146.2 | 1 |
| 18 | 2-domain-containing | 1 |
| 19 | 310,163 | 1 |
| 20 | 31kd | 1 |
| 21 | 818-11130 | 1 |
| 22 | allocation.in | 1 |
| 23 | amond | 1 |
| 24 | bengal-encapsulated | 1 |
| 25 | betwee | 1 |
| 26 | betwees | 1 |
| 27 | class.the | 1 |
| 28 | cpda-induced | 1 |
| 29 | cysteine-stabilized | 1 |
| 30 | d'accueil | 1 |
| 31 | difference=- | 1 |
| 32 | dual-x | 1 |
| 33 | effective.when | 1 |
| 34 | heart360 | 1 |
| 35 | inboth | 1 |
| 36 | inone | 1 |
| 37 | inserum | 1 |
| 38 | language.in | 1 |
| 39 | medications-between | 1 |
| 40 | n-palmitoylethanolamine-transpolydatin | 1 |
| 41 | nnt.with | 1 |
| 42 | nonsynbiotic-containing | 1 |
| 43 | ofscar | 1 |
| 44 | p24-specific | 1 |
| 45 | rz-2000 | 1 |
| 46 | régionale | 1 |
| 47 | separately.in | 1 |
| 48 | studies-does | 1 |
| 49 | surgery-biopsy | 1 |
| 50 | tour-sanctioned | 1 |
| 51 | type-43a | 1 |
| 52 | vasotonic | 1 |
| 53 | ö. | 1 |
| 54 | −0.5 | 1 |
| 55 | −27.6 | 1 |
| 1 | -138.31 | 1 |
| 2 | -33.39 | 1 |
| 3 | 0·138 | 1 |
| 4 | 11/0402 | 1 |
| 5 | 13.9±25.6 | 1 |
| 6 | 13/0503 | 1 |
| 7 | 1403.3 | 1 |
| 8 | 16.3-146.2 | 1 |
| 9 | 2-containing | 3 |
| 10 | 2-domain-containing | 1 |
| 11 | 310,163 | 1 |
| 12 | 31kd | 1 |
| 13 | 818-11130 | 1 |
| 14 | allocation.in | 1 |
| 15 | amond | 1 |
| 16 | be-tween | 2 |
| 17 | bengal-encapsulated | 1 |
| 18 | betwee | 1 |
| 19 | betweem | 2 |
| 20 | between | 184,635 |
| 21 | betwees | 1 |
| 22 | bewteen | 2 |
| 23 | class.the | 1 |
| 24 | cpda-induced | 1 |
| 25 | cysteine-stabilized | 1 |
| 26 | d'accueil | 1 |
| 27 | difference=- | 1 |
| 28 | dual-x | 1 |
| 29 | effective.when | 1 |
| 30 | heart360 | 1 |
| 31 | inboth | 1 |
| 32 | inone | 1 |
| 33 | inserum | 1 |
| 34 | language.in | 1 |
| 35 | medications-between | 1 |
| 36 | n-palmitoylethanolamine-transpolydatin | 1 |
| 37 | nnt.with | 1 |
| 38 | nonsynbiotic-containing | 1 |
| 39 | ofboth | 2 |
| 40 | ofscar | 1 |
| 41 | p24-specific | 1 |
| 42 | rz-2000 | 1 |
| 43 | régionale | 1 |
| 44 | separately.in | 1 |
| 45 | studies-does | 1 |
| 46 | surgery-biopsy | 1 |
| 47 | tour-sanctioned | 1 |
| 48 | type-43a | 1 |
| 49 | uring | 2 |
| 50 | vasotonic | 1 |
| 51 | vc-da | 4 |
| 52 | ö. | 1 |
| 53 | of | 2 |
| 54 | −0.5 | 1 |
| 55 | −27.6 | 1 |
| 1 | difference=- | 1 |
| 2 | ö. | 1 |
| 3 | rz-2000 | 1 |
| 4 | 818-11130 | 1 |
| 5 | heart360 | 1 |
| 6 | -138.31 | 1 |
| 7 | 16.3-146.2 | 1 |
| 8 | 11/0402 | 1 |
| 9 | 1403.3 | 1 |
| 10 | 13/0503 | 1 |
| 11 | 310,163 | 1 |
| 12 | −0.5 | 1 |
| 13 | 13.9±25.6 | 1 |
| 14 | −27.6 | 1 |
| 15 | 0·138 | 1 |
| 16 | -33.39 | 1 |
| 17 | type-43a | 1 |
| 18 | vc-da | 4 |
| 19 | p24-specific | 1 |
| 20 | vasotonic | 1 |
| 21 | cpda-induced | 1 |
| 22 | tour-sanctioned | 1 |
| 23 | bengal-encapsulated | 1 |
| 24 | cysteine-stabilized | 1 |
| 25 | 31kd | 1 |
| 26 | amond | 1 |
| 27 | betwee | 1 |
| 28 | class.the | 1 |
| 29 | régionale | 1 |
| 30 | inone | 1 |
| 31 | of | 2 |
| 32 | 2-containing | 3 |
| 33 | nonsynbiotic-containing | 1 |
| 34 | 2-domain-containing | 1 |
| 35 | uring | 2 |
| 36 | nnt.with | 1 |
| 37 | ofboth | 2 |
| 38 | inboth | 1 |
| 39 | d'accueil | 1 |
| 40 | betweem | 2 |
| 41 | inserum | 1 |
| 42 | bewteen | 2 |
| 43 | be-tween | 2 |
| 44 | between | 184,635 |
| 45 | medications-between | 1 |
| 46 | effective.when | 1 |
| 47 | language.in | 1 |
| 48 | allocation.in | 1 |
| 49 | separately.in | 1 |
| 50 | n-palmitoylethanolamine-transpolydatin | 1 |
| 51 | ofscar | 1 |
| 52 | betwees | 1 |
| 53 | studies-does | 1 |
| 54 | dual-x | 1 |
| 55 | surgery-biopsy | 1 |